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Abstract: 
     Bryophyllum calycinum  belongs  to the family crassulaceae  was widely used in traditional medicine 
especially in the tropical areas. The plant contained alkaloids, phenols, flavonoids, tannins, anthocyanins,   
glycosides, bufadienolides, saponins, coumarins, sitosterols, quinines, carotenoids, tocopherol and lectins
 . The  
previous pharmacological studies showed that it  exerted many pharmacological effects including anticancer , 
antioxidant immunomodulating  , antibacterial , anthelmentic , antiprotozoal , neurologica ( sedative and 
anticonvulsant) , anti-inflammatory , analgesic , diuresis , antiurolithitic , nephroprotective, hepatoprotective , 
anti-peptic ulcer , hypotensive , antidiabetic , wound healing and other pharmacological effects. The present 
review was designed to highlight  the chemical constituents and pharmacological effects of Bryophyllum 
calycinum. 
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Introduction: 
Physicochemical 
    Bryophyllum calycinum ( Synonyms: Kalanchoe pinnatum, Bryophyllum pinnatum)
 (1) , belongs to the family 
crassulaceae  was commonly known as sprouting leaf . It was  found in the tropical parts, southern Africa, and 
American
  (2).  The leaves and leaf juice  of the plant were   used    traditionally  as antiviral, antipyretic, 
antimicrobial , anti-inflammatory , antitumor , hypocholesterolemic, antioxidant, diuretic, antiulcer, styptic, 
antidiabetic, astringent, antiseptic, antilithic and cough suppressant
(3-11). Phytochemical studies showed that the 
plant contained alkaloids, phenols, flavonoids, tannins, anthocyanins, glycosides, bufadienolides, saponins, 
coumarins, sitosterols, quinines, carotenoids, tocopherol and lectins
 (12-19)
Physicochemical properties:  
. The pharmacological studies showed 
that it exerted many pharmacological effects including anticancer , antioxidant immunomodulating , 
antibacterial , anthelmentic , antiprotozoal , ,neurologica ( sedative and anticonvulsant ) , anti-inflammatory , 
analgesic , diuresis , antiurolithitic , nephroprotective, hepatoprotective , anti-peptic ulcer , hypotensive , 
antidiabetic , wound healing and other pharmacological effects. The present review aimed to provide detail 
information  regarding the chemical constituents and pharmacological effects of Bryophyllum calycinum. 
    Total ash 5.1% , acid insoluble ash 1.69% , water soluble ash 4.19% , water soluble extractive value 19.80%,  
and  alcohol soluble extractive value 5.60%
(12)
Chemical constituents: 
.   
    Phytochemical studies showed that the plant contained alkaloids, phenols, flavonoids, tannins, anthocyanins,   
glycosides, bufadienolides, saponins, coumarins, sitosterols, quinines, carotenoids, tocopherol and lectins
 (13-19). 
Protein nitrogen and soluble nitrogen in the excised leaves of Bryophyllum calycinum were  0.97- 1.38  and  
0.37- 0.81  g /kg respectively
 (20)
Leaves of Bryophyllum calycinum contained many acids including malic acid, isocitric acid, oxalic acid and 
succinic acid
. 
 (21). Threo -Ds-isocitric acid as the mono-potassium salt of the lactone was also isolated from dried 
Bryophyllum calycinum leaf tissue. The overall yield was  49 to 62% of the isocitric acid in the organic acid 
extract
 (22).  However , syringic acid, caffeic acid, 4-hydroxy-3-methoxy-cinnamic acid, 4- hydroxybenzoic acid, 
p-  hydroxycinnamic acid, paracoumaric acid, ferulic acid, protocatechuic acid, phosphoenolpyruvate, 
protocatechuic acid  were also isolated from aerial parts of plants
(17,23-24).  The leaves contained  flavones, 
falvans, flavanones, isoflavonoids, chalcones, aurones , anthocyanidines , 5 Methyl 4, 5, 7 trihydroxyl flavone 1 
, 4, 3, 5, 7 tetrahydroxy 5-methyl 5I-propenamine anthocyanidines2 , 24-epiclerosterol (R)-stigmasta-5, 25-
dien-3β-ol], 24(R)- 5α-stigmasta-7, 25-dien-3β-ol, 5α-stigmast-24-en-3β-ol and 25-methyl-5α-ergost-24 (28)-
en-3β-ol, 1-octane3-O-α-L-arabinopyranosyl-(1-6)-glucopyranoside , isorhamnetin-3-O-a-L-1C4-
rhamnopyranoside, 40-methoxy-myricetin-3-O-a-L 1C4-rhamnopyranoside and protocatechuic-40-O-b-D-4C1-
gluco-pyranoside , bersaldegenin-  1, 3, 5-orthoacetate , bufadienolide-  bryophyllin B , bryophyllin C ,   
Stigmast-4, 20 (21), 23-trien-3-one , stigmata-5-en-3β-ol , α – amyrin- β-D-glucopyranoside  and  nundecanyl 
n-octadec-9-en-1-oate and n-dodecanyl noctadec- 9-en-1-oate
(25-31). The plant  also contained calcium(96.45 
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ascorbic acid (26.42 to 44.03 mg/100 g), riboflavin (0.20 to 0.42 mg/100 g), thiamine (0.11 to 0.18 mg/100 g), 
niacin (0.02 to 0.09 mg/100 g),  casein hydrlylsate and   nicotinamide
(12,30,32-33)
Pharmacological effects: 
 . 
Anticancer effects: 
     The antitumor effect of Bryophyllum calycinum Salisb. was evaluated against Ehrlich ascites 
carcinoma (EAC) bearing Swiss albino mice. The effect of methanol and aqueous extracts of Bryophyllum 
calycinum  on tumor growth was  evaluated by , the percentage inhibition of ascetic cells and percentage 
inhibition of tumor weight. Methanol and aqueous extracts were administered at doses of 100,200 and 400 
mg/kg body weight intraperitonially once a day for 7 days, after 24h of tumor inoculation. Decreases in tumor 
cell count and tumor weight were observed in extract treated animals when compared to EAC treated animals. 
The results were dose dependent in case of methanol extract
 (2). Five bufadienolides isolated from the leaves of 
the plant  were examined for their inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation in 
Raji cells induced by the tumor promoter,12- Otetradecanoylphorbol-13-acetate. All bufadienolides showed 
inhibitory activity, and bryophyllin A exhibited the most marked inhibition among the tested compounds.   
Bryophyllin C and bersaldegenin-3-acetate were less active
 (34)
Immunomodulatory effects: 
. 
    Mice treated  daily with oral B.pinnatum during hypersensitization with ovalbumin were protected against 
death. Oral protection was accompanied by a reduced production of  OVA-specific IgE antibodies, reduced 
eosinophilia, and impaired production of the IL-5, IL-10 and TNF-  α  cytokines.  Oral  treatment  with  the 
quercitrin flavonoid isolated from plant extract prevented fatal anaphylaxis in 75% of the animals. These 
findings indicated that oral treatment with Bryophyllum pinnatum effectively downmodulates pro-anaphylactic 
reactions  inducing immune responses
 (35). The aqueous extract of  leaves causes significant inhibition of cell-
mediated and humoral immune responses in mice .The spleen cells of animals pretreated with plant extract 
showed a decreased ability to proliferate in response to both mitogen and antigen in vitro as well as, the specific 
antibody responses to ovalbumin were also significantly reduced by treatment
(36)
Antimicrobial effects: 
.  
     The antimicrobial effects of petroleum ether, chloroform, methanol and aqueous extracts was evaluated in 
vitro  against  Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and  Candida albicans. 
Methanolic extract of roots was found to be most effective antibacterial compared to others, while none of 
extract showed the activity against C. albicans
 (37)
Agar cup plate test was used to determine the sensitivity of the tested  Bryophyllum calycinum Salisb leaf 
extracts  and  the micro-dilution method was used to determine the minimum inhibitory concentration.  The 
aqueous extract was active against all tested microbial strains (Gram-positive :Staphylococcus aureus ATCC 
25925, Bacillus subtilis ATCC 6633, Staphylococcus epidermis ATCC 12228 and Micrococcus luteus ATCC 
10240 ; and Gram-negative : Enterobacter aerogens ATCC 13048, Escherichia coli ATCC 25922, Salmonella 
typhi ATCC 51812 and Shigella dysenteriae ATCC 25931). The aqueous extract showed antimicrobial activity 
against all tested microorganism with minimum inhibitory concentration ranging between 0.26 to 2.08 mg/ml, 
while , the MICs of  alcoholic extract ranged between 1.04 to 8.32 mg/ml
. 
  (1). Flavonoids , (5 methyl 4,5,7 
trihydroxyl flavone and 4,3,5,7 tetrahydroxy 5-methyl 5-propenamine anthocyanidines) possessed significant 
antimicrobial activity against Pseudomonas aeruginosa, Klebsiella pneumonia, E.coli, Staphylococcus aureus, 
Candida albicans and Aspergillus niger
(30,38)
Anthelmentic and antiprotozoal effects: 
. 
    The crude extracts contained tannins which produced anthelmentic activity. The chloroform, methanolic and 
aqueous extract of the plant root cause paralysis and deaths of worms and showed significant anthelmentic 
activity
 (12, 39). The antileishmanial effect of the plant extracts and its flavonoids components was evaluated in 
vivo  in murine model of cutaneous  leishmaniasis. Quercetin 3-  O-α-L-arabinopyranosyl,  α-L-
rhamnopyranoside, quercetin 3-O-α-L- rhamno pyranoside and free quercetin were able to control the lesion 
growth caused by Leishmania amazonensis and significantly reduce the parasite load. These flavonoids were as 
effective as the crude aqueous extract which indicated that the antileishmanial effect could be attributed to 
flavonoids
 (40-41)
Antioxidant effects: 
.  
    The DPPH and nitric oxide free radical scavenging method were used to detect oxidative activity of   
Bryophyllum calycinum Salisb leaf extracts. The results of DPPH method showed 50% inhibition rate at the 
144.23μg/ml  and  117.42μg/ml  with  aqueous  and  alcoholic  extract,  respectively.  Nitric  oxide  scavenging 
inhibition showed 50% inhibition rate at the 525.92μg/ml and 460.48μg/ml with aqueous and alcoholic extract, 
respectively
(1). 
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    Sedative effects: 
   The methanolic extract of Bryophyllum calycinum Salisb showed neuropharmacological effects  in 
experimental animals (rats and mice).  The fraction produced alteration of behavior  pattern, caused dose-
dependent potentiation of pentobarbitone sleeping time and had significant analgesic activity and possesses a 
potent CNS depressant action. The saline leaf extract of Bryophyllum calycinum Salisb produced  a dose-
dependent prolongation of onset and duration of pentobarbitone-induced hypnosis, reduction of exploratory 
activities in the head-dip and evasion tests. Moreover, a dose-dependent muscle in-coordination was observed in 
the inclined screen, traction and climbing tests in mice . The saline leaf extract produced a dose-dependent 
prolongation of onset and duration of pentobarbitone-induced hypnosis, reduction of exploratory activities in 
the head-dip and evasion tests and a dose-dependent muscle incoordination in the inclined screen, traction and 
climbing tests
 (19, 31,  42)
    Anticonvulsant effect: 
. 
    The CH2Cl  2/CH3OH extract reduced seizures induced by pentylenetetrazol, strychnine  sulphate and 
thiosemicarbazide and increases in the latency period of seizures and  reduced the duration of seizures induced 
by the three convulsive agents
 (31,43-44)
Anti-inflammatory and analgesic effects: 
. 
    The plant extract significantly inhibited fresh egg albumin-induced acute inflammation  and  significantly 
exhibited antinociceptive effects against thermally- and chemically-induced nociceptive pain stimuli in mice
(45).  
Stigmast-4, 20 (21), 23-trien-3-one, a steroidal derivative obtained from the leaves extract of the plant , also 
possessed anti-inflammatory effects
(31)
The aqueous extract of Bryophyllum calycinum  leaves were showed antinociceptive, anti-inflammatory and 
antidiabetic activity. The antinociceptive effect was evaluated by the  hot-plate and acetic acid test models of 
pain in mice. The anti-inflammatory and antidiabetic effects were investigated in rats, using fresh egg albumin-
induced pedal (paw) odema, and streptozotocin -induced diabetes mellitus
. 
(45)
Effects on renal system: 
. 
    The  aqueous extract of the leaves   possessed  potent nephroprotective activity in gentamycin-induced 
nephrotoxicity in rats. The  plant hydroalcoholic  extract was also  found to exert  significant diuresis and 
antiurolithitic activity when given  by oral and ip route to rats
(39,46-47)
Hepatoprotective effects: 
. 
    The plant was recorded as  hepatoprotectitve . It was  significantly lowers the enzyme SGOT, SGPT , SALP 
and SBLN which increased during liver injury . The juice of the leaves and the ethanolic extract of the marc left 
after expressing the juice were also found hepatoprotective against CCl4- induced hepatotoxicity. It was also 
hepatoprotective at histopathological level
 (48-50). The juice of the leaves and the ethanolic extract of the marc 
left after expressing  were studied in rats against CCl4-induced hepatotoxicity. It was found  that they were 
effective hepatoprotective as evidenced by in vitro, in vivo and histopathological studies. The juice was found to 
be more effective than  the ethanolic extract
 (12)
Effects on reproductive system: 
.  
    The plant exerted relaxant effect in vitro on the contractility of human myometrium on oxytocin-stimulated 
contraction at a minimum concentration almost 100-fold lower than in the case of spontaneous contraction
 (51). 
A prospective double-blind trial with orally applied Bryophyllum versus placebo was carried out. Thirty-two 
patients divided into two groups , 15 patients received Bryophyllum and 17 received the placebo. The time of 
delivery did not differ between the groups. In both groups the mean time of birth was in the 35 week of 
gestation. The mean birth weight was slightly higher in the placebo group (2192g) compared to the 
Bryophyllum group (1948g). A transition to the intensive care unit was slightly higher in the placebo group 
(13) compared to the Bryophyllum group (11)
 (52)
Gastrointestinal effects: 
. 
    The methanol-soluble fraction of the leaf extract inhibited the development of a variety of acute ulcers 
induced in the stomach and duodenum of rats and guinea pigs. Premedication tests in rats revealed that the 
extract possessed significant protective action against the gastric lesions induced by aspirin, indomethacin, 
serotonin, reserpine, stress and ethanol.  A significant protection with extract was occurred for aspirin-induced 
ulcer in pylorus-ligated rats and for histamine-induced duodenal lesions in guinea pigs. A significant 
enhancement of the healing process was also occurred in acetic acid-induced chronic gastric lesions in rats
 (53)
 
.  
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    The aqueous and methanolic leaf extracts decreased  arterial blood pressures and heart rates of anaesthetized 
normotensive and hypertensive rats
 (54).  The effects of aqueous and methanolic leaf extracts of the herb were 
examined on arterial blood pressures and heart rates of normal (normotensive) and spontaneously hypertensive 
rats, using invasive and non-invasive techniques. Both the aqueous and methanolic leaf extracts of the plant ( 
50-800 mg/kg iv or ip) produced dose-related, significant (P<0.05 - 0.001) decreases in arterial blood pressures 
and heart rates of anaesthetized normotensive and hypertensive rats. The hypotensive effects of the leaf extracts 
were more pronounced in the hypertensive than in normotensive rats. The leaf extracts ( 0.25 - 5.0 mg/ml) also 
produced dose-dependent significant (P<0.05 -0.001) decreases in the rate and force of contractions of guinea-
pig isolated atria, and inhibited  provoked electrical field stimulation (ES-provoked) , as well as potassium and 
receptor-mediated agonist drugs-induced contractions of the rat isolated thoraxic aortic strips in a non-specific 
manner. The inhibitory effects of the leaf extracts on the cardiovascular system of the laboratory animals  were 
resistant to physiological doses  of standard antagonist drugs
 (54, 55)
Wound healing: 
. 
    The ethanolic extract of the leaves of the plant was evaluated for its wound healing activity by using excision 
wound model in rats. The histological investigation   showed that plant leaf ethanolic extract  exhibited 
significant wound healing potential which   could be attributed to the presence of steroid glycosides
 (56)
Antidiabetic effects: 
. 
    The plant aqueous extract of B. pinnatum caused significant reductions in the blood glucose levels of the 
fasted normal and fasted streptozotocin –treated diabetic rats
 (12, 45, 57)
Antihistaminic effect: 
.  
    The methanol extract of the leaves has also been reported to have histamine receptor (H1) antagonism in the 
ileum, peripheral vasculature and bronchial muscle
 (58)
Contraindications and adverse effects: 
. 
    In acute toxicity study, it was observed that the LD50 values of methanolic extract in mice and rats were 
1159.03 and 1459.69 mg/kg respectively and  the LD50 of aqueous extract  were  957.02 and 1064.21 mg/kg 
respectively. The extracts were found to be non-toxic orally in doses up to 3 g/kg body weight in mice and rats. 
2 g/ kg body weight orally for 35 days in rats didn’t cause histological changes in kidneys, hearts and spleen. 
No changes in body weight, hematological and biochemical parameters. There was no death at a maximum 
acute dose of 5 g kg/ body weight by the oral route. The intraperitoneal LD50 was 1.8 g/ kg body weight in rats . 
Subacute treatment did not significantly alter animal weights, organ-to-body weight ratios, fluid intake, 
hematological indices and the levels of AST, ALP and albumin. ALT level was significantly reduced (p<0.03) 
in the treated group. Total bilirubin and conjugated bilirubin levels were not significantly altered in the treated 
group
 (12, 59-60)
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